| Name | Title | Contact Details |
|---|
HBK CPAs & Consultants is a multidisciplinary financial services firm based in Canfield, Ohio, with operations in several states, including Pennsylvania, New Jersey, New York, and Florida. Established in 1949, HBK is one of the largest accounting firms in the U.S., ranking 46th in recent listings. The firm is dedicated to collaboration and a holistic approach to client service, emphasizing integrity, respect, and transparency. HBK offers a comprehensive range of financial services tailored for small to mid-market businesses. Their offerings include accounting and audit services, tax planning and compliance, wealth management through HBKS Wealth Advisors, business valuation, corporate finance, forensic accounting, and business consulting. With a client base of over 20,000, HBK provides customized solutions to meet the unique financial needs of its clients. The firm has also received recognition from notable publications for its excellence in wealth management services.
TAG Restaurant Group (TRG) is a Denver-based restaurant collection founded by Chef Troy Guard. Beginning in 2009 with a continentally-charged restaurant located on Denvers historic Larimer Square, TRG has evolved into a culinary powerhouse, garnering local and national attention as well as many accolades along the way. TRG currently operates four concepts over eleven locations in the Denver metro area, and Houston: Los Chingones (four locations), Guard and Grace Denver and Houston, Bubu (three locations), and HashTAG (est. 2017). TAG Restaurant Group strives to shake up your typical dining by offering immersive culinary experiences deeply rooted in and inspired by Chef Troys life and travels. They are crafted with genuine hospitality in mind and are never shy to produce bold, worldly flavors using local ingredients. More than the sum of their parts, TRGs brands represent a way of life and a celebration of the unexpected. The feeling of an Ohana (Hawaiian word for Family) passionately pursuing culinary excellence is tangible. Here, stories are made, told, and remembered. We operate under one vision. The TAG Restaurant Group is a celebration of the unexpected! We will deliver our guests an inspiring vibe with a memorable experience. Our intense focus will be on impeccable service. We will go above and beyond to pursue culinary excellence and grow the TAG Restaurant Group with our OHANA. Our staff exemplifies our core values: Passion, Imagination, Caring, Courage, Harmony, Humility, and Ownership. We look forward to serving you soon, Bon Appetit!
AirBoss of America Corp. is a leading developer and manufacturer of advanced custom rubber compounds and finished rubber products. Founded in 1989 and headquartered in Newmarket, Ontario, Canada, the company operates multiple facilities in Canada and the United States. Originally known as IATCO Industries Inc., AirBoss has grown from manufacturing segmented tires to providing innovative solutions in industrial rubber products, personal protective equipment (PPE), and survivability solutions. The company offers a diverse range of products across various industries. This includes rubber compounds for automotive, heavy industry, and construction, as well as PPE for military, law enforcement, and healthcare professionals. AirBoss also develops survivability solutions, such as rapid deployment negative pressure isolation shelters. With a focus on quality and innovation, AirBoss serves customers in automotive, healthcare, defense, and industrial sectors, ensuring safety and reliability in their products. The company operates through several subsidiaries, enhancing its capabilities in rubber compounding and defense-related solutions.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.